Trial Search Results

Microfracture Versus Adipose Derived Stem Cells for the Treatment of Articular Cartilage Defects

The purpose of this study is to compare two biologic methods for the treatment of articular cartilage defects in the knee. The first method, microfracture, is the standard of care and is routinely used to recruit cells from the subchondral bone marrow to the site of cartilage loss. The second method is the application of adipose-derived stem cells (ADSCs) to the defect site. In theory, ADSCs on a collagen scaffold should enable the delivery of more specific progenitor cells to the site of injury, resulting in better regeneration and integration of articular cartilage at the site of a defect as compared to the microfracture method.

Stanford is currently accepting patients for this trial.

Lead Sponsor:

Stanford University

Collaborator: University of Kentucky

Stanford Investigator(s):

Intervention(s):

  • Procedure: ADSC Application
  • Procedure: Microfracture

Phase:

N/A

Eligibility


Inclusion Criteria:

   - Must be between ages 18 and 50 years.

   - Must have a discrete, contained chondral defect less than 400mm^2 located on the
   medial or lateral femoral condyle

   - Must have overall neutral lower limb mechanical alignment (<5 degrees varus or
   valgus).

Exclusion Criteria:

   - Ages younger than 18 years and older than 50 years.

   - If they have undergone previous chondral procedures

   - If they have pre-existing osteoarthritis (Kellegren-Lawrence Grade ≥2)

   - If they have a BMI >30.

Ages Eligible for Study

18 Years - 50 Years

Genders Eligible for Study

All

Now accepting new patients

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Jan Yabut
650-721-7780
Recruiting